138 related articles for article (PubMed ID: 38806876)
1. Surgical marker navigation system in breast conserving surgery and excision of non-palpable lesions: first Spanish single-center experience.
Santana Valenciano Á; Rivas Fidalgo S; Corral Moreno S; Gamero Medina V; Martín Blanco C; Pérez Izquierdo CB; Mena Mateos A; Cabañas Montero J; Fernández Cebrián JM
Breast Cancer Res Treat; 2024 May; ():. PubMed ID: 38806876
[TBL] [Abstract][Full Text] [Related]
2. A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer: a pilot study.
Follacchio GA; Monteleone F; Anibaldi P; De Vincentis G; Iacobelli S; Merola R; D'Orazi V; Monti M; Pasta V
J Exp Clin Cancer Res; 2015 Oct; 34():113. PubMed ID: 26445493
[TBL] [Abstract][Full Text] [Related]
3. Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions.
Look Hong N; Wright FC; Semple M; Nicolae AM; Ravi A
Breast Cancer Res Treat; 2020 Feb; 179(3):671-676. PubMed ID: 31754951
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience of the Magseed
Crèvecoeur J; Jossa V; Di Bella J; Coibion M; Crèvecoeur A
Gland Surg; 2023 May; 12(5):566-576. PubMed ID: 37284712
[TBL] [Abstract][Full Text] [Related]
5. Localization techniques for guided surgical excision of non-palpable breast lesions.
Chan BK; Wiseberg-Firtell JA; Jois RH; Jensen K; Audisio RA
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009206. PubMed ID: 26718728
[TBL] [Abstract][Full Text] [Related]
6. Combined use of magnetic seed and tracer in breast conserving surgery with sentinel lymph node biopsy for non-palpable breast lesions: A pilot study describing pitfalls and solutions.
van Haaren ERM; Martens MH; Spiekerman van Weezelenburg MA; van Roozendaal LM; Frotscher CNA; Körver-Steeman RRM; Lobbes MBI; van Bastelaar J; Vissers YLJ; Janssen A
Surg Oncol; 2023 Feb; 46():101905. PubMed ID: 36706578
[TBL] [Abstract][Full Text] [Related]
7. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial.
Postma EL; Verkooijen HM; van Esser S; Hobbelink MG; van der Schelling GP; Koelemij R; Witkamp AJ; Contant C; van Diest PJ; Willems SM; Borel Rinkes IH; van den Bosch MA; Mali WP; van Hillegersberg R;
Breast Cancer Res Treat; 2012 Nov; 136(2):469-78. PubMed ID: 23053639
[TBL] [Abstract][Full Text] [Related]
9. Radioactive seed localisation of non-palpable lymph nodes - A feasibility study.
Hassing CMS; Tvedskov TF; Kroman N; Klausen TL; Drejøe JB; Tvedskov JF; Lambine TL; Kledal H; Lelkaitis G; Langhans L
Eur J Surg Oncol; 2018 May; 44(5):725-730. PubMed ID: 29545086
[TBL] [Abstract][Full Text] [Related]
10. Magnetic seed versus skin tattoo localization of non-palpable breast lesions: a single institution cohort study.
D'Angelo A; Scardina L; Palma S; Cicero SL; Maresca A; Caprini F; Biondi E; Franco A; Terribile D; Franceschini G; Belli P; Manfredi R
Eur Radiol; 2024 Jan; 34(1):149-154. PubMed ID: 37526666
[TBL] [Abstract][Full Text] [Related]
11. Sentinel node occult lesion localization technique for impalpable breast cancer.
Hubley S; Barton R; Snook KL; Spillane A
ANZ J Surg; 2020 Dec; 90(12):2510-2515. PubMed ID: 33124171
[TBL] [Abstract][Full Text] [Related]
12. Axillary node interventions in breast cancer: a systematic review.
Rao R; Euhus D; Mayo HG; Balch C
JAMA; 2013 Oct; 310(13):1385-94. PubMed ID: 24084924
[TBL] [Abstract][Full Text] [Related]
13. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
[TBL] [Abstract][Full Text] [Related]
14. The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.
van der Noordaa ME; Pengel KE; Groen E; van Werkhoven E; Rutgers EJ; Loo CE; Vogel W; Vrancken Peeters MJ
Eur J Surg Oncol; 2015 Apr; 41(4):553-8. PubMed ID: 25707349
[TBL] [Abstract][Full Text] [Related]
15. A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery.
Hersi AF; Eriksson S; Ramos J; Abdsaleh S; Wärnberg F; Karakatsanis A
Eur J Surg Oncol; 2019 Apr; 45(4):544-549. PubMed ID: 30401506
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative ultrasound in conservative surgery for non-palpable breast cancer after neoadjuvant chemotherapy.
Ramos M; Díez JC; Ramos T; Ruano R; Sancho M; González-Orús JM
Int J Surg; 2014; 12(6):572-7. PubMed ID: 24735893
[TBL] [Abstract][Full Text] [Related]
17. Comparison of wire-guided localization (WGL) and radio-guided occult lesion localization (ROLL) in localization of non-palpable breast lesions.
Elzohery YH; Gomaa MM; Mohamed G; Fadlalla WM; Taha SN; Ibraheem MH
World J Surg Oncol; 2023 Aug; 21(1):266. PubMed ID: 37626332
[TBL] [Abstract][Full Text] [Related]
18. Nonimage-guided fine needle aspiration biopsy of palpable axillary lymph nodes in breast cancer patients.
Marti JL; Ayo D; Levine P; Hernandez O; Rescigno J; Axelrod DM
Breast J; 2012; 18(1):3-7. PubMed ID: 22098412
[TBL] [Abstract][Full Text] [Related]
19. The Sentinel Node and Occult Lesion Localization (SNOLL) Technique Using a Single Radiopharmaceutical in Non-palpable Breast Lesions.
Okudan B; Seven B; Arıcan P
Curr Med Imaging; 2024 Jan; ():. PubMed ID: 38284704
[TBL] [Abstract][Full Text] [Related]
20. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
